• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Light-Responsive Nanomaterials for Cancer Therapy

    2022-08-17 01:51:08XuZhngShengWngGuohuiChengPengYuJinChng
    Engineering 2022年6期

    Xu Zhng, Sheng Wng,*, Guohui Cheng, Peng Yu, Jin Chng,b,*

    a School of Life Sciences, Tianjin University, Tianjin 300072, China

    b Tianjin Engineering Center of Micro–Nano Biomaterials and Detection–Treatment Technology, Tianjin 300072, China

    Keywords:Light-responsive Nanomaterials Cancer Phototherapy

    ABSTRACT Due to its unique advantages,which include minimal invasiveness and relative clinical safety,phototherapy is considered to be a promising approach for cancer treatment. However, the treatment efficacy of phototherapy is often restricted by the limited depth of light penetration and the low targeting effect of phototherapeutic agents.The emergence of light-responsive nanomaterials offers a possible approach to achieve enhanced phototherapy potency.This review summarizes the progress in biomedical applications of light-responsive nanomaterials for cancer therapy, which include photothermal therapy (PTT),photodynamic therapy(PDT),light-responsive molecule delivery,and light-controlled combination therapy. Future prospects are also discussed. This review aims to demonstrate the significance of lightresponsive nanomaterials in cancer therapy and to provide strategies to expand the applications of phototherapy.

    1. Introduction

    In recent years,phototherapy has received a great deal of attention due to its advantages of spatiotemporal addressability, minimal invasiveness, and relative clinical safety [1,2]. As early as 1903, Niels Ryberg Finsen—the founder of modern phototherapy—was awarded the Nobel Prize for treating a skin disease(lupus vulgaris) using sunlight and ultraviolet (UV) radiation[3,4]. Since then, phototherapy has been continuously developed in biomedical engineering to combat skin diseases (e.g., eczema,psoriasis, and itchy skin) and mood and sleep disorders (e.g., seasonal affective disorder[5,6],non-seasonal depression[7],and circadian rhythm sleep disorders [8]). With the aid of phototherapeutic agents, such as photosensitizers and photothermal conversion agents (PTCAs), phototherapy has also proved to be an effective approach to ablate tumors [9].

    Light sources that are commonly applied in cancer phototherapy include UV light (100–400 nm), visible light (400–760 nm),and near-infrared (NIR) light (760–1350 nm). However, due to the absorption of biological tissues, the widely used UV light and visible light have limited tissue penetration depth [10], which restricts traditional phototherapy to superficial tumors and may lead to the risk of relapse and metastasis [1,11]. In addition, low targeting efficiency caused by the nonspecific distribution of phototherapeutic agents is an important issue that must be addressed.Untargeted delivery of phototherapeutic agents in therapy procedures will not only lead to low bioavailability and poor efficacy,but also cause side effects.

    With the development of nanotechnology, various phototherapeutic nanoagents based on versatile nanomaterials have been exploited to overcome the abovementioned limitations in cancer phototherapy [12–14]. Nanoagents with a specific size range(20–200 nm) accumulate in tumor tissue due to the enhanced permeation and retention (EPR) effect [15–17]. Therefore, nanomaterials hold potential to serve as carriers to deliver therapeutic molecules such as photosensitizers, PTCAs, drugs, and genes to tumor tissue, thereby achieving targeted therapy and combination therapy [18–20]. In order to address the issue of limited light penetration depth in phototherapy, NIR-light-responsive nanomaterials have been developed. For example, PTCAs that can directly absorb NIR light and generate heat have been used for NIR-triggered photothermal therapy (PTT). Upconversion nanoparticles (UCNPs), which can absorb long-wavelength NIR light and emit specific short-wavelength UV or visible light, have been used as a transducer to realize deeper penetration [21,22].Thus, light-responsive nanomaterials offer the possibility of overcoming the obstacles in and expanding the applications of phototherapy.

    In this review, we summarize recent advances in lightresponsive nanomaterials for cancer therapy (Table 1 [23–47]).These nanomaterials can be applied in PTT,photodynamic therapy(PDT), light-responsive molecule delivery, and light-controlled combination therapy (Fig. 1). We also discuss current challenges and prospects in phototherapy. The purpose of this review is to emphasize the significant role of light-responsive nanomaterials in cancer phototherapy and to provide further directions to expand their applications.

    2. Light-responsive nanomaterials

    Light-responsive nanomaterials that are used in cancer phototherapy include PTCAs,nanophotosensitizers,and nanoplatforms containing light-responsive moieties. PTCAs are agents that can capture light energy and convert it into heat to trigger cancer cell death. In general, PTCAs can be divided into two categories:organic materials and inorganic materials. Common organic PTCA materials include organic dye molecules (e.g., indocyanine green(ICG)) and organic nanoparticles (NPs) (e.g., semiconducting polymer NPs) [48,49]. Inorganic PTCA materials include noble metal materials (e.g., gold (Au) nanomaterials), transition metal chalcogenides and oxides (e.g., copper sulphide (CuS) NPs), and carbonbased materials (e.g., graphene oxide) [50].

    Photosensitizers can be activated by light with a specific wavelength to generate reactive oxygen species(ROS)and damage cancer cells through local oxidative stress [51]. Photosensitizers can also be divided into organic materials and inorganic materials.Organic photosensitizers include organic dye molecules such as porphyrin and boron-dipyrromethene (BODIPY), while inorganic photosensitizers include titanium dioxide (TiO2), zinc oxide(ZnO), graphitic carbon nitride (g-C3N4), and more [52,53].

    Table 1 Summary of light-responsive nanomaterials in cancer therapy.

    Fig. 1. Schematic illustration of applications of light-responsive nanomaterials in cancer therapy. NPs: nanoparticles.

    Many light-responsive nanoplatforms have been designed and developed by exploiting light-responsive linkers, such as azobenzene[54].These nanoplatforms can be used as efficient nanocarriers to realize light-responsive molecule delivery. In addition to designing such nanoplatforms to directly respond to light, lightresponsive nanomaterials can be designed to respond via a cascade strategy[55].For example,nanomaterials composed of photothermal agents (PTAs) and thermal-sensitive linkers can respond to light irradiation. Moreover, light-induced ROS generation can lead to the cleavage of some chemical bonds,such as thioketal(TK)linkers, thereby achieving light-triggered drug release [56].

    3. Photothermal therapy

    PTT is a promising treatment with minimal invasiveness and high therapeutic effects in cancer therapy [57]. Under irradiation by external light, PTCAs absorb light energy and convert it into heat, which kills cancer cells. PTCAs usually need to have high NIR absorption and high photothermal conversion efficiency. In the past decades, various nanomaterial-based PTCAs, such as Au nanomaterials, black phosphorus (BP), niobium carbide, graphene,metallic/nonmetallic compounds, and organic dye, have been developed for PTT [23–26,58–60]. For example, El-Sayed et al.[61] reported that gold nanorod (GNR)-assisted plasmonic PTT is a potential and effective alternative to traditional surgery.Furthermore,GNR PTT can decrease the collective migration of cancer cells by regulating and remodeling actin filaments and cell junction proteins [62]. De Sio et al. [27] reported a keratin-coated biomimetic gold NP (Ker-AuNP) that can be used as a highly efficient PTCA for plasmonic PTT.

    Zhang et al. [28] developed an inorganic nanotheranostic agent (Gd:CuS@bovine serum albumin (BSA) NPs) based on gadolinium (Gd)-integrated copper sulphide (CuS) NPs (Fig. 2(a)). Due to the strong NIR absorbance of the Gd:CuS NPs [63–65] and the good biocompatibility achieved by the BSA modification [66], the nanotheranostic agent (Gd:CuS@BSA NPs) can be used as an excellent nanotheranostic agent for in vivo photoacoustic (PA)/magnetic resonance imaging (MRI) guidance and effective PTT. As shown in Fig. 2(b), under NIR laser irradiation,the temperature of the Gd:CuS@BSA NPs clearly increased, indicating the good photothermal effect of Gd:CuS. Moreover, the Gd:CuS@BSA NPs exhibited the continuous enhancement of in vivo PA/MRI signals within 24 h on tumor-bearing mice(Fig. 2(c)). Dual-modal imaging facilitated imaging-guided phototherapy, resulting in potent tumor elimination. To verify the PTT effect of the Gd:CuS@BSA NPs in vitro, a cytotoxicity study and live/dead cell co-staining were carried out on SK-OV-3 cells.As shown in Figs. 2(d) and (e), the relative viabilities of the tumor cells were obviously decreased upon laser irradiation,which demonstrated the tumor-ablation effect of Gd:CuS@BSA.The photothermal effect of Gd:CuS@BSA was also demonstrated in vivo. As shown in real-time thermal images (Fig. 2(f)), when treated with Gd:CuS@BSA NPs, the temperature of the tumor sites increased by 21°C, which was significantly higher than the temperature increase in the control group (6°C). Under NIR laser irradiation, the tumor exhibited remarkable regression, followed by complete elimination (Fig. 2(g)), which demonstrated the significant tumor-ablation effect of PTT.

    Apart from inorganic nanomaterials, organic nanoagents play essential roles in cancer PTT. For example, US Food and Drug Administration (FDA)-approved ICG, a highly biocompatible NIR organic dye, has been widely applied in PTT due to its various energy level transition pathways upon NIR light excitation[67,68]. In addition, Pu et al. [29] reported semiconducting polymer nanoenzymes (SPNs) with an NIR photothermic effect for enhanced cancer therapy. As shown in Fig. 3(a), the SPNs contain a semiconducting polymer amphiphile (PCB) as a photothermal nanotransducer and bromelain (Bro) as a temperature-sensitive enzyme. Under NIR laser irradiation, the local temperature increased due to the photothermal conversion activity of the SPNs,leading to the photothermic activation of Bro. Therefore, collagen,the most abundant protein in the tumor extracellular matrix [69],was digested in situ,resulting in the improved tumor accumulation of SPNs and enhanced PTT.Upon 808 nm laser irradiation,the temperatures of the PCB1-Bro group were obviously increased, both in vitro (Fig. 3(b)) and in vivo (Fig. 3(c)), which verified the high photothermal conversion efficiency of PCB1-Bro. Moreover, the penetration depth of PCB1-Bro with NIR laser irradiation was evidently enhanced in comparison with the penetration depth without laser irradiation, confirming that photothermal-enhanced collagen digestion had occurred. As shown in Fig. 3(d), after the photothermic activation of the Bro enzyme,the tumor fluorescence signals of the PCB1-Bro-treated group were higher than those of other groups, indicating enhanced tumor accumulation of PCB1-Bro due to collagen digestion. The efficient accumulation of PCB1-Bro further led to a higher tumor temperature and stronger tumor growth inhibition (Figs. 3(c) and (e)).

    Fig.2. (a)Schematic illustration of Gd:CuS@BSA hybrid theranostic agents for imaging-guided tumor PTT.MRI:magnetic resonance imaging.(b)Infrared thermal images of an aqueous Gd:CuS@BSA NPs droplet of a Gd:CuS@BSA NP and a deionized water droplet with NIR laser irradiation(980 nm).(c)PA/MRI(dual-modal imaging)of an SK-OV-3 tumor before and after Gd:CuS@BSA treatment. (d)Viability of SK-OV-3 cells treated with Gd:CuS@BSA NPs and laser irradiation (980 nm, 0.6 W?cm-2,5 min).Ctrl: control group(treated with 0 μg?mL-1 Gd:CuS@BSA NPs).(e)Fluorescence staining of live/dead SK-OV-3 cells after treatment with different formulations.(f)In vivo thermal imaging of an SK-OV-3 tumor treated with different formulations followed by laser irradiation (980 nm, 5 min). (g) Growth curves of an SK-OV-3 tumor treated with different formulations. Reproduced from Ref. [28] with permission of American Chemical Society, ? 2016.

    Due to the advantages of PTT,some PTCAs have already entered clinical trials. In 2019, the results of a phase I trial demonstrated the feasibility of an approach involving gold–silica nanoshells for the focal PTT ablation of prostate tumors[70].In addition,in order to further improve the light penetration depth, NIR-II lightresponsive PTCAs have gained increased research attention. For example, Yang et al. [71] developed a polyethylene glycol-graftpolyethylenimine-modified hollow carbon nanosphere for NIR-II laser-activated cancer PTT.

    4. Photodynamic therapy

    PDT is a clinically approved modality that has been used for more than 40 years in the treatment of cancers, including superficial skin lesions, esophageal tumors, and lung tumors [48]. There are three essential elements in PDT: oxygen, a photosensitizer,and light [72]. Hundreds of photosensitizers have been applied for PDT clinically or preclinically, including porphyrin, chlorin,and phthalocyanine derivatives[73,74].In a conventional PDT process, photosensitizers transfer light energy to surrounding molecules to generate cytotoxic ROS for cancer treatment [75–77].There are two main types of photodynamic reaction—type I and type II. In the mechanism of a type I reaction, a triplet-state photosensitizer reacts with cellular substrates directly via electron transfer,resulting in the generation of free radicals.The generated radicals then react with oxygen (O2) to produce oxygenated products, including superoxide anions (O2-), hydrogen peroxide(H2O2),and hydroxyl radicals (·OH). Alternatively, in the mechanism of a type II reaction, a triplet photosensitizer transfers energy directly to oxygen (3O2) to produce highly reactive singlet oxygen (1O2)[14,73,76]. Most of the existing PDT systems adopt the oxygendependent type II mechanism [78].

    Fig. 3. (a) Schematic illustration of PCB1-Bro for photothermally enhanced NP accumulation in tumors. EDC/NHS: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide/Nhydroxysuccinimide. (b) Temperature changes of different samples upon laser irradiation. (c) Infrared thermal images of 4T1 tumor-bearing mice treated with different formulations and laser irradiation (808 nm, 5 min). (d) Real-time fluorescence images of 4T1 tumor-bearing mice treated with different formulations with/without laser irradiation. (e) Growth curves of a 4T1 tumor with different treatments. PBS: phosphate buffered saline. Reproduced from Ref. [29] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Compared with other conventional therapeutic methods, PDT possesses several advantages, including minimal invasiveness, the spatial accuracy of the operation, minimal side effects, non-drug resistance, and a short recovery period [79]. However, PDT also has major restrictions,including the hypoxic condition of the tumor,the low targeting efficiency of the photosensitizer,and limited light penetrationdepth.In addition,the nonspecific distributionof photosensitizers causes phototoxicity in normal tissues, which must be taken into consideration. Due to stringent requirements regarding biocompatibility and the frontier orbitals of the molecular motifs,the choice of efficient molecular photosensitizers remains limited[30].To address these problems,many novel photosensitizers with versatile properties have been developed to enhance the efficacy of PDT. For example, porous covalent organic frameworks (COFs)with excellent ROS production efficiency have been developed by linking ROS-inert molecular motifs [30]. To enhance the effects of PDT in deep tissues, a combination of UCNPs and photosensitizers is an efficient approach[80].Xing et al.[81]proposed a strategy to achieve highly efficacious PDT by integrating UCNPs with graphene quantum dots(GQDs).UCNPs can serve as light transducers to convert NIR light into visible light for photosensitizer activation, thus greatly expanding the applicability of PDT.

    Moreover, some studies have demonstrated that the radicals generated via a type I photoreaction can amplify PDT response,especially under hypoxic conditions [82]. Based on this, Yoon et al. [83] reported a nanostructured phthalocyanine assembly(NanoPcA), which has a favorable antibacterial effect through enhanced type I PDT. Jiang et al. [31] developed a type I nanoagent—namely, dihydrolipoic-acid-coated gold nanoclusters(AuNC@DHLA)—for two-photon anticancer PDT.In this nanoagent,Au nanoclusters are used as a promising photosensitizer due to their excellent biocompatibility and long fluorescence tripletstate lifetime [84]. In another study, Lin et al. [32] reported a nanoscale metal–organic framework (NMOF) based on 5,10,15,20-tetra (p-benzoato) bacteriochlorin (TBB) ligands(denoted as Zr-TBB) for enhanced PDT via both type I and type II mechanisms(Fig.4(a)).As a nanophotosensitizer,NMOF possesses the unique properties of high photosensitizer loading efficacy, a porous structure, and intrinsic biodegradability[85].Bacteriochlorin exhibits excellent absorption in the NIR region (700–850 nm)and can be used for type I PDT under hypoxic conditions [86].However, the PDT efficacy of bacteriochlorin is significantly restricted by its instability to oxygen and light [87,88]. The structure of NMOF is beneficial for stabilizing bacteriochlorin’s ligands,thereby preventing unimolecular photodecomposition and selfquenching. As shown in the confocal laser scanning microscopy(CLSM) images in Fig. 4(b), four types of ROS (O2-, H2O2,·OH, and1O2) were produced in the Zr-TBB group, confirming the presence of light-induced type I and type II PDT processes. Accordingly,Zr-TBB exhibits excellent in vivo antitumor efficacy against both subcutaneous 4T1 and MC38 tumors (Fig. 4(c)).

    Traditional photosensitizers, such as porphyrin derivatives, are hydrophobic and tend to aggregate in aqueous solution.The aggregation state of photosensitizers causes fluorescence quenching,which reduces the ROS production efficiency and greatly limits the PDT treatment outcome [89,90]. To address this issue, Chen et al.[91]developed a single molecular nanophotosensitizer based on a porphyrin nanocage. Due to the rigid structure of the nanocages, the π–π stacking interaction between the photosensitizers is inhibited, which promotes the photosensitizing effect.

    The development of aggregation-induced emission(AIE)photosensitizers provides another strategy to overcome the quenching effect of traditional photosensitizers [92,93]. Recently, Tang et al.[33]proposed a ‘‘1 + 1 +1 >3” synergistic strategy based on three AIE luminogens(AIEgens).The AIEgens have the same photosensitizer backbone but different targeting groups that can target mitochondria, the cell membrane, and lysosomes, respectively (Fig.5(a)). As shown in Fig. 5(b), after cellular uptake by 4T1 cells, the three AIEgens manifested excellent co-localization with corresponding organelles. The tumor-inhibition effect of this three-inone group was found to be better than that of each photosensitizer alone, which was ascribed to the synergistic PDT strategy (Fig.5(c)).

    Due to the nonspecific biodistribution of photosensitizers,most photosensitizers will trigger phototoxicity when patients are exposed to sunlight. To reduce the phototoxicity, activatable PDT is a promising strategy. For example, Li et al. [34] developed an AIE-photosensitizer-loaded liposome (AIE-PS@liposome) to achieve controlled photosensitization. As shown in Fig. 5(d), the photosensitivity of the AIE-PS entrapped in the lipid bilayer is in an ‘‘OFF” state; however, once the AIE-PS@liposomes reach tumor sites, the AIE-PS are released for in situ reaggregation, leading to activated PDT.As expected,the AIE-PS@liposomes exhibited much lower phototoxicity under both laser and sunlight irradiation in comparison with the control groups, which included AIE-PS nanoaggregates and the commercial photosensitizer chlorin e6(Ce6) (Fig. 5(e)).

    5. Light-responsive molecule delivery

    The low targeting of therapeutic agents in cancer therapy results in unsatisfactory efficacy and severe side effects in normal tissues. With the development of stimuli-responsive delivery systems, an increasing number of nanocarriers based on polymeric and inorganic nanomaterials have been exploited to realize the targeted delivery of drugs, photosensitizers, genes, and so forth [94–98]. As an external stimulus, light has unique features for controlling the release behaviors of therapeutic agents at precise locations and avoiding individual variability [35,99]. For example, thermalresponsive nanomaterials can achieve light-triggered drug delivery via photothermal-induced linker cleavage, structural changes in nanocarriers, radical generation, and other pathways [36–39].The ROS produced by photosensitizers under light irradiation can also lead to on-demand drug delivery by triggering the cleavage of ROS-sensitive linkers, such as TK linker [40,100].

    Fig.4. (a)Schematic illustration of bacteriochlorin ligands stabilized in Zr-TBB for type I and type II PDT.(b)CLSM images of ROS generation in 4T1 cells treated with different formulations after light irradiation.Scale bars:20 μm.(c)Growth curves of a 4T1 tumor and an MC38 tumor treated with different formulations.Reproduced from Ref.[32]with permission of American Chemical Society, ? 2020.

    Fig. 5. (a) Chemical structures and schematic illustration of three AIEgens for synergistically enhanced PDT. (b) Co-localization of the AIEgens in CLSM images of 4T1 cells treated with different formulations.(c)Growth curves of a 4T1 tumor treated with different formulations.(d)Schematic illustration of AIE-PS@liposomes for activatable PDT.DSPE-PEG: distearoylphosphatidylethanolamine-poly(ethylene glycol) 2000; DMPC: 1,2-dimyristoyl-sn-glycero-3-phosphocholine. (e) Blood vessels in ears treated with different formulations. (a)–(c) Reproduced from Ref. [33] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2020; (d) and (e) reproduced from Ref. [34] with permission of American Chemical Society, ? 2019.

    Liang et al. [41] developed diazirine (DA)-decorated human serum albumin (HSA) nanomedicines (denoted as HSA dNMs) for the co-encapsulation of photosensitizer(ICG)and the prodrug tirapazamine (TPZ) via electrostatic and hydrophobic interactions(Fig. 6(a)). As shown in Fig. 6(b), under 405 nm laser irradiation,the DA groups transformed into reactive carbine moieties and reacted with the adjacent HSA dNMs for crosslinking, leading to improved tumor accumulation and retention of ICG/TPZ@HSA dNMs. Next, 808 nm laser irradiation triggered hyperthermia and ROS generation for tumor PTT and PDT. In addition, the oxygen consumption in the PDT process led to hypoxia aggravation and TPZ activation to achieve synergistic therapy. The lightresponsive delivery of HSA dNMs was confirmed by both in vitro and in vivo results.The size of the HSA dNMs with DA modification was clearly increased after exposure to a laser at 405 nm(Fig.6(c)),which verified the UV-light-triggered aggregation behavior. The tumor accumulation of the ICG/TPZ@HSA dNMs in vivo was represented by the imaging contrast index (CI) calculated from the fluorescent signal ratio of tumor to tissue [101]. The CI values of the UV-laser-treated group were significantly higher than those of the control group without laser irradiation, confirming the laserenhanced tumor accumulation behavior of the ICG/TPZ@HSA dNMs(Fig. 6(d)).Consistent results were obtained,based on biodistribution fluorescence images. As shown in Fig. 6(e), the fluorescence intensity of the tumors was significantly increased after laser treatment. This elaborate design of ICG/TPZ@HSA dNMs enhanced the targeted delivery of ICG/TPZ and improved the anticancer efficacy through light-induced aggregation and cascade phototherapy/chemotherapy.

    Aside from the delivery of drugs and photosensitizers,nanomaterials can be applied for the light-controlled selective activation of gene expression in gene therapy. For example, optogenetics is a combination of optical and genetic methods to precisely control the expression of proteins in specific cells,so as to control intracellular biological processes and behaviors [102]. Like most lighttriggered delivery systems that rely on UV/visible light irradiation,the activation of the photo-actuator in optogenetics is seriously restricted by the limited light penetration depth [103–105]. To address this issue, UCNPs can serve as a nanotransducer to transform external NIR light with deep penetration depth into local UV/visible light for the noninvasive activation of photoreceptors in vivo [106,107].

    Fig.6. Light-responsive drugs/photosensitizers delivery system for cancer therapy.(a)Schematic illustration of ICG/TPZ@HSA dNMs for cascaded synergistic cancer therapy triggered by laser irradiations(405 and 808 nm).CT:chemotherapy.(b)Scheme of 405 nm laser-induced aggregation of ICG/TPZ@HSA dNMs.(c)Size changes of HSA dNMs with different sequential laser irradiation times. (d) Tumor accumulation of ICG/TPZ@HSA dNMs, as represented by CI values. (e) In vivo biodistribution of ICG/TPZ@HSA dNMs in 4T1 tumor-bearing mice. T/N: the fluorescence signal ratio of tumor to tissue; p.i.: postinjection. Reproduced from Ref. [41] with permission of Wiley-VCH Verlag GmbH & Co. KGaA, ? 2018.

    Chang et al. [108] developed an upconversion optogenetic nanosystem composed of UCNPs, arabidopsis flavoprotein cryptochrome 2 (Cry2), and its interacting partner Cib1 plasmids. The UCNPs play a part in both plasmid DNA (pDNA) delivery and light transformation. External NIR-light-triggered local blue light emitting noninvasively induces photoreceptor Cry2 and Cib1 interaction, which activates the apoptotic signaling pathway of cancer cells. In another effort, Chang’s group [35] reported on an NIRcontrolled gene-delivery system based on mesoporous silica(mSiO2)@polyethyleneimine (PEI) nanocarrier-conjugated upconverting rods (UCRs) (Fig. 7(a)). Upon NIR light irradiation, the external NIR light is converted into UV light by the UCRs to trigger the cleavage of o-nitrobenzyl groups (Fig. 7(b)). As a result, the gene-loaded mSiO2@PEI nanocarriers are released for gene delivery(Fig.7(c)).This gene expression study reported that the genes were released and expressed upon NIR irradiation,confirming that lightcontrolled precisely regulated gene expression at high spatial and temporal resolutions had been achieved.

    6. Light-controlled combination therapy

    Although phototherapy techniques have been developed in recent years,some drawbacks of single-mode phototherapy,which relies on only one therapeutic method,remain to be resolved,such as relapse or metastasis in the treatment of persistent tumors [1].To address this issue, combination phototherapy with immunotherapy, gene therapy, chemotherapy, chemodynamic therapy (CDT), and other therapy methods can maximize the advantages of each therapeutic pattern and achieve complementary multitherapeutic efficacy [109,110].

    Photo-immunotherapy, which can eliminate primary tumors and induce host immunity in order to control distant metastases,is considered to be a promising strategy for the treatment of metastatic cancer [111]. For example, Wang et al. [42] developed an injectable red blood cell (RBC)-based gel for cancer photoimmunotherapy. After the subcutaneous injection of imiquimod(R837) adjuvant engineered RBCs, a hydrogel-like composition spontaneously formed due to the infiltrated platelets and thrombin. The photothermal effect of the in situ-formed RBC gel led to the photoablation of tumors and the production of tumorassociated antigens,thereby initiating adaptive immune responses to cancer.Moreover,the released immunoadjuvant,R837,induced robust and persistent immune responses for cancer metastasis/recurrence inhibition.

    Liang et al.[43]developed an‘‘a(chǎn)ll-in-one”theranostic nanomedicine based on CuInS/ZnS(ZCIS)quantum dots(QDs)for synergistic PTT/PDT therapy. QDs have been widely used in tumor diagnosis and treatment due to their high fluorescence intensity and broad excitation spectrum [44,112,113]. The efficient absorption effect of ZCIS QDs in the range of 650–750 nm has enabled noninvasive fluorescence/multispectral optical tomography imaging. Furthermore, the photothermal and photodynamic effects of ZCIS QDs could be used for cancer treatment (Fig. 8(a)).

    In addition,Chang et al.[45]reported a multifunctional nanotheranostic agent (PB@PEI/HSP70-p53-GFP NP) based on human HSP70 promoter-loaded Prussian blue (PB) nanocubes for NIR light-triggered PTT/gene combination therapy. As shown in Fig.8(b), due to the photothermal property of the PB nanocubes, the HSP70 promoter was activated under mild NIR laser irradiation(≈41°C),resulting in tumor suppressor p53-dependent apoptosis.Under strong NIR laser irradiation (≈50°C), both PTT and gene therapy were activated. Thus, the synergistic antitumor efficacy can be adjusted by the NIR laser irradiation.

    Fig. 7. Light-responsive gene delivery and expression. (a) Synthetic procedure for the mSiO2@PEI gene nanocarrier and the UCR substrate. APTES: 3-aminopropyl triethoxysilane;TEOS:tetraethyl orthosilicate;PAA:poly(acrylic acid).(b)Schematic illustration of the light-triggered release of mSiO2@PEI gene nanocarriers from the UCR substrate due to photocleavage of o-nitrobenzyl groups. (c) Fluorescence images of the substrate immobilized with rhodamine-loaded mSiO2@PEI nanocarriers with or without NIR laser (980 nm, 8.9 W?cm-2, 12 min). Reproduced from Ref. [35] with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2015.

    The combination of chemotherapy and phototherapy is another important approach to realize synergistic therapy. Qian et al. [46]developed an ROS-responsive prodrug delivery nanoplatform for a combination of chemotherapy and PDT. As shown in Fig. 8(c),the chemotherapeutic drug camptothecin(CPT)and the photosensitizer pyropheophorbide-a (PPa) were conjugated to methoxypolyethylene glycol (MPEG) to prepare a polyprodrug, which further self-assembled into nanomedicine. The fluorescent PPa precisely located the tumor site and guided laser irradiation. Next,the ROS generated from the PPa-mediated PDT process broke the ROS-responsive TK linker between the polymer and CPT, leading to controlled release of the CPT drugs. This combination of chemotherapy and PDT exhibited a more effective antitumor effect than monotherapy.

    Similar to PDT, CDT involves the generation of highly oxidative hydroxyl radicals for tumor treatment [114–117]. Tang et al. [47]constructed a programmed release system (NMOF@dihydroartemisinin (DHA)@calcium carbonate (CaCO3)) based on DHA-loaded ferrum(Fe)-(4,4,4,4-(porphine-5,10,15,20-tetrayl)tetrakis(benzoic acid)) (TCPP)NMOF with CaCO3mineralized coating(Fig.8(d)).The weak acidity of the tumor microenvironment led to the dissolution of the CaCO3layer, resulting in Ca2+release. Once the NMOF@DHA entered cancer cells, the high glutathione (GSH)level inside the cells led to Fe3+reduction and TCPP activation,due to NMOF skeleton collapse. Therefore, NMOF@DHA@CaCO3was able to realize Ca2+-DHA-mediated oncosis therapy, Fe2+-DHA-mediated CDT, and TCPP-mediated PDT.

    7. Conclusions and future perspectives

    Light-induced phototherapy has been widely used to combat cancers due to its minimal invasiveness and minor side effects[118]. However, the efficacy of phototherapy is restricted by the limited depth of light penetration and the untargeted distribution of phototherapeutic agents. The emergence of light-responsive nanomaterials provides a promising approach to address these issues due to the specific properties of such nanomaterials, which include their nanoscale size,multifunctional surface modifications,and controllable synthesis.As a result,enhanced phototherapy has been achieved through the rational design of light-responsive nanomaterials.

    This review summarized recent advances in light-responsive nanomaterials for cancer therapy, including PTT, PDT, lightresponsive molecule delivery, and light-controlled combination therapy. To achieve precise cancer phototherapy and accelerate clinical transformation, the following aspects should be taken into consideration:

    (1) Limitation of light penetration depth. The penetration depth of light relies on the light wavelength. UV light and visible light are mainly applied in the treatment of superficial skin diseases due to their limited penetration depth. In addition, light is attenuated to a large extent when it interacts with tissues, which hinders the applications of phototherapy, especially in the treatment of deep-tissue tumors. Although the application of UCNPs provides an approach to increase light penetration depth, UCNPs still have the disadvantage of low conversion efficiency.Compared with the NIR-I window(750–1000 nm),the NIR-II window(1000–1350 nm) exhibits reduced light scattering, minimized tissue absorption,and higher maximum permissible laser exposure;thus,it seems to be a prospective candidate for achieving deep-tissue penetration depth [119,120]. Therefore, NIR-II-responsive nanomaterials show great potential for expanding the application of phototherapy.

    Fig.8. Light-controlled combination cancer therapy.(a)Schematic illustration of ZCIS QDs in the combination therapy of PTT and PDT.FL:fluorescence;MSOT:multispectral optoacoustic tomography; US: ultrasound;ΔT: temperature increase. (b) Schematic illustration of PB@PEI/HSP70-p53-GFP NPs in the combination therapy of gene therapy and PDT. (c) Schematic illustration of MPEG–(TK–CPT)–PPa in the combination therapy of chemotherapy and PDT. (d) Schematic illustration of NMOF@DHA@CaCO3 in the combination therapy of CDT and PDT.(a)Reproduced from Ref.[43]with permission of American Chemical Society,?2016;(b)reproduced from Ref.[45]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2018;(c)reproduced from Ref.[46]with permission of Wiley-VCH Verlag GmbH&Co.KGaA,?2020;(d)reproduced from Ref.[47]with permission from Wiley-VCH Verlag GmbH & Co. KGaA, ? 2019.

    (2) Risk of potential toxicity. In the light-triggered molecule delivery process of phototherapy, the uncontrolled burst release of drugs from nanocarriers leads to short-term toxicity,while slow and incomplete metabolism of nanomaterials may result in longterm toxicity [121]. Furthermore, the untargeted biological distribution of light-responsive nanotherapeutic agents may cause sunlight-exposure-induced systemic toxicity. In order to realize precise controllable cancer phototherapy, an ideal nanomedicine should only be activated at the tumor site, and should maintain an ‘‘OFF” state in normal tissues. Therefore, the development of activatable phototherapeutic agents that can respond to the typical characteristics of the tumor microenvironment is an effective way to address the issue of phototoxicity.

    (3)Clinical transformation.In order to achieve multifunctional cancer therapy, nanomaterials are usually complex in both design and composition, which undoubtedly introduces difficulties into their clinical transformation. In addition, due to the unknown toxicity mechanism of some newly developed nanomaterials, the clinical application of these nanomaterials requires complex toxicity-assessment procedures.

    Acknowledgments

    This work was supported by the National Natural Science Foundation of China (32000991 and 51873150), the Young Elite Scientists Sponsorship Program by Tianjin (TJSQNTJ-2020-02), the Key Project of Tianjin Foundational Research(Jing–Jin–Ji)Program(19JCZDJC64100), and the Tianjin Research Innovation Project for Postgraduate Students (2020YJSB130).

    Compliance with ethics guidelines

    Xu Zhang, Sheng Wang, Guohui Cheng, Peng Yu, and Jin Chang declare that they have no conflict of interest or financial conflicts to disclose.

    久久久久久久久中文| 一进一出好大好爽视频| 久久久精品大字幕| av视频在线观看入口| 久久久久久人人人人人| 欧美另类亚洲清纯唯美| 久久中文字幕一级| 91字幕亚洲| 成人欧美大片| 亚洲色图 男人天堂 中文字幕| 在线观看一区二区三区| 一个人看视频在线观看www免费 | 变态另类丝袜制服| 久久精品91蜜桃| 欧美最黄视频在线播放免费| 亚洲人成电影免费在线| 淫秽高清视频在线观看| 少妇人妻一区二区三区视频| 亚洲在线观看片| 国产亚洲av高清不卡| 精品久久久久久久久久久久久| www.www免费av| 丰满的人妻完整版| 变态另类成人亚洲欧美熟女| 校园春色视频在线观看| 又大又爽又粗| 美女高潮喷水抽搐中文字幕| 亚洲一区二区三区色噜噜| 精品久久久久久久人妻蜜臀av| 亚洲人与动物交配视频| 视频区欧美日本亚洲| 国产三级在线视频| 欧美绝顶高潮抽搐喷水| 女人被狂操c到高潮| 啪啪无遮挡十八禁网站| 岛国视频午夜一区免费看| 免费在线观看影片大全网站| 网址你懂的国产日韩在线| 亚洲欧美一区二区三区黑人| 精品久久久久久,| 一个人看视频在线观看www免费 | 亚洲精品乱码久久久v下载方式 | 又粗又爽又猛毛片免费看| 亚洲天堂国产精品一区在线| 亚洲欧美日韩卡通动漫| 亚洲精品一区av在线观看| 制服人妻中文乱码| 久久久久久久精品吃奶| 亚洲精品在线美女| 91老司机精品| 国模一区二区三区四区视频 | 久久亚洲真实| 国产高清激情床上av| av在线蜜桃| 国产亚洲精品一区二区www| 美女扒开内裤让男人捅视频| 18禁美女被吸乳视频| 成人三级黄色视频| 天天一区二区日本电影三级| 久久久久国产一级毛片高清牌| 俄罗斯特黄特色一大片| 亚洲片人在线观看| 国产精品av视频在线免费观看| 丁香欧美五月| 又黄又爽又免费观看的视频| 亚洲狠狠婷婷综合久久图片| 身体一侧抽搐| 在线观看舔阴道视频| 精品久久久久久成人av| 99热只有精品国产| 国产又黄又爽又无遮挡在线| 色综合亚洲欧美另类图片| 中文字幕最新亚洲高清| 国产高清激情床上av| 真实男女啪啪啪动态图| 亚洲成人中文字幕在线播放| 女人被狂操c到高潮| 色在线成人网| www.熟女人妻精品国产| 亚洲片人在线观看| 欧美一级a爱片免费观看看| 综合色av麻豆| 欧美不卡视频在线免费观看| 欧美成人一区二区免费高清观看 | 此物有八面人人有两片| x7x7x7水蜜桃| 搡老妇女老女人老熟妇| 久99久视频精品免费| 国产男靠女视频免费网站| 日韩欧美在线乱码| 亚洲男人的天堂狠狠| 精品欧美国产一区二区三| 亚洲无线在线观看| 搡老岳熟女国产| 日本熟妇午夜| 在线播放国产精品三级| 18禁黄网站禁片午夜丰满| 最近视频中文字幕2019在线8| 亚洲精品在线观看二区| 日韩国内少妇激情av| 日韩大尺度精品在线看网址| 很黄的视频免费| a在线观看视频网站| 九色成人免费人妻av| 日本黄色视频三级网站网址| 国产探花在线观看一区二区| 桃色一区二区三区在线观看| 啪啪无遮挡十八禁网站| 亚洲av日韩精品久久久久久密| 欧美午夜高清在线| 美女大奶头视频| 一级黄色大片毛片| 天天一区二区日本电影三级| 可以在线观看毛片的网站| 亚洲天堂国产精品一区在线| 国产精品亚洲av一区麻豆| 一个人观看的视频www高清免费观看 | 国产精品,欧美在线| 99久久久亚洲精品蜜臀av| 久久久久国产精品人妻aⅴ院| 欧美日韩国产亚洲二区| 看黄色毛片网站| 熟女少妇亚洲综合色aaa.| 精品无人区乱码1区二区| 久久久久国内视频| 天堂√8在线中文| 久久久久久久久久黄片| 亚洲av成人精品一区久久| 亚洲人成电影免费在线| 欧美激情在线99| 亚洲av美国av| 亚洲熟女毛片儿| 美女扒开内裤让男人捅视频| 禁无遮挡网站| 亚洲精品一区av在线观看| 少妇的丰满在线观看| 哪里可以看免费的av片| 欧美高清成人免费视频www| 夜夜爽天天搞| ponron亚洲| 天堂网av新在线| 搡老妇女老女人老熟妇| 此物有八面人人有两片| 九色国产91popny在线| 久久久久精品国产欧美久久久| 免费看日本二区| aaaaa片日本免费| 18禁黄网站禁片午夜丰满| 国产精华一区二区三区| 国产精品久久视频播放| 观看美女的网站| 亚洲狠狠婷婷综合久久图片| 欧美午夜高清在线| 91av网一区二区| 一进一出抽搐动态| 51午夜福利影视在线观看| 国产黄a三级三级三级人| 久久亚洲精品不卡| 成人三级黄色视频| 国产精品久久久av美女十八| 日韩欧美国产一区二区入口| 波多野结衣高清无吗| 国产爱豆传媒在线观看| 我的老师免费观看完整版| 不卡一级毛片| 国内精品美女久久久久久| 国产精品久久久久久久电影 | 级片在线观看| 亚洲男人的天堂狠狠| 成人亚洲精品av一区二区| 欧美另类亚洲清纯唯美| 国产成人啪精品午夜网站| 久久伊人香网站| 久久午夜综合久久蜜桃| 色综合欧美亚洲国产小说| 在线看三级毛片| 欧美丝袜亚洲另类 | 狠狠狠狠99中文字幕| cao死你这个sao货| 欧美zozozo另类| 欧美xxxx黑人xx丫x性爽| 一边摸一边抽搐一进一小说| 亚洲欧美一区二区三区黑人| 高清毛片免费观看视频网站| 日韩av在线大香蕉| 久久久久久久午夜电影| 亚洲九九香蕉| 一夜夜www| 亚洲狠狠婷婷综合久久图片| 观看美女的网站| 岛国在线免费视频观看| 日本a在线网址| 日本 欧美在线| 性色avwww在线观看| 真人一进一出gif抽搐免费| 日韩有码中文字幕| 99久久国产精品久久久| 午夜激情福利司机影院| 亚洲成人久久爱视频| 欧美色欧美亚洲另类二区| 日本黄色片子视频| 欧洲精品卡2卡3卡4卡5卡区| 级片在线观看| 成人欧美大片| 日韩欧美在线乱码| 成人永久免费在线观看视频| 中文字幕高清在线视频| 久久精品国产综合久久久| 国产1区2区3区精品| 日韩欧美国产在线观看| 99久久成人亚洲精品观看| 法律面前人人平等表现在哪些方面| 国内久久婷婷六月综合欲色啪| 欧美黑人巨大hd| av国产免费在线观看| 欧美av亚洲av综合av国产av| 老汉色∧v一级毛片| 2021天堂中文幕一二区在线观| 天堂动漫精品| 国产av不卡久久| 美女黄网站色视频| 久久天堂一区二区三区四区| 成人国产一区最新在线观看| 亚洲中文字幕一区二区三区有码在线看 | 精品99又大又爽又粗少妇毛片 | 欧美日韩乱码在线| 嫩草影院精品99| 国产精品女同一区二区软件 | 国产黄片美女视频| 欧美乱色亚洲激情| 成人一区二区视频在线观看| 99热精品在线国产| 一区二区三区国产精品乱码| 国产aⅴ精品一区二区三区波| 久久久久精品国产欧美久久久| 欧美一级a爱片免费观看看| 韩国av一区二区三区四区| 日本一本二区三区精品| 美女高潮喷水抽搐中文字幕| 十八禁网站免费在线| 国产成人福利小说| 日韩欧美免费精品| 性色av乱码一区二区三区2| 亚洲国产欧美人成| 国产精品精品国产色婷婷| 欧美成人性av电影在线观看| 国模一区二区三区四区视频 | 亚洲第一欧美日韩一区二区三区| 两人在一起打扑克的视频| 操出白浆在线播放| 18禁黄网站禁片午夜丰满| 日本撒尿小便嘘嘘汇集6| 精品99又大又爽又粗少妇毛片 | 免费搜索国产男女视频| 亚洲色图 男人天堂 中文字幕| 免费在线观看成人毛片| 特大巨黑吊av在线直播| 久久久久久久久免费视频了| 99久久99久久久精品蜜桃| 欧美日韩瑟瑟在线播放| 老司机在亚洲福利影院| 午夜两性在线视频| 最好的美女福利视频网| 国产免费av片在线观看野外av| 亚洲欧美日韩东京热| 成人精品一区二区免费| 在线十欧美十亚洲十日本专区| 国产午夜福利久久久久久| 97碰自拍视频| 久久久久久人人人人人| 亚洲av成人不卡在线观看播放网| 免费看a级黄色片| 久久婷婷人人爽人人干人人爱| АⅤ资源中文在线天堂| 欧美性猛交╳xxx乱大交人| 国产成人精品久久二区二区91| 69av精品久久久久久| 欧美乱妇无乱码| 亚洲成av人片免费观看| 久久久国产精品麻豆| 香蕉久久夜色| 床上黄色一级片| 日韩欧美在线乱码| 国内毛片毛片毛片毛片毛片| 中文字幕熟女人妻在线| 成人午夜高清在线视频| 别揉我奶头~嗯~啊~动态视频| 99久久成人亚洲精品观看| 无限看片的www在线观看| 不卡一级毛片| www日本黄色视频网| 一个人免费在线观看的高清视频| 一边摸一边抽搐一进一小说| 欧美3d第一页| 夜夜躁狠狠躁天天躁| 99国产精品一区二区三区| 欧美+亚洲+日韩+国产| 中文字幕人妻丝袜一区二区| 免费人成视频x8x8入口观看| 亚洲第一欧美日韩一区二区三区| 18禁美女被吸乳视频| 最近在线观看免费完整版| 成人亚洲精品av一区二区| 搡老熟女国产l中国老女人| 亚洲电影在线观看av| 波多野结衣高清作品| 亚洲av日韩精品久久久久久密| 久久中文看片网| 亚洲精品国产精品久久久不卡| 欧美xxxx黑人xx丫x性爽| 免费观看的影片在线观看| 99riav亚洲国产免费| 精品熟女少妇八av免费久了| 欧美成狂野欧美在线观看| 成人鲁丝片一二三区免费| 成人欧美大片| 亚洲欧美精品综合一区二区三区| 日韩欧美国产一区二区入口| 亚洲国产看品久久| 国产精品一区二区三区四区久久| or卡值多少钱| 毛片女人毛片| xxx96com| 欧美一区二区精品小视频在线| 久久中文字幕一级| 久久久久精品国产欧美久久久| 一个人看视频在线观看www免费 | 两个人看的免费小视频| 国产午夜精品论理片| 欧美一区二区精品小视频在线| 国产蜜桃级精品一区二区三区| 极品教师在线免费播放| 亚洲人成电影免费在线| 国产高清videossex| 欧美日韩国产亚洲二区| 麻豆久久精品国产亚洲av| 一a级毛片在线观看| 90打野战视频偷拍视频| 国产亚洲av嫩草精品影院| 老司机福利观看| 丁香六月欧美| 亚洲国产高清在线一区二区三| 男人舔女人下体高潮全视频| 露出奶头的视频| 黄片大片在线免费观看| 国产单亲对白刺激| 看片在线看免费视频| 亚洲成人免费电影在线观看| 国产一区二区在线观看日韩 | 手机成人av网站| 国产爱豆传媒在线观看| 久久天堂一区二区三区四区| 两个人视频免费观看高清| 精品无人区乱码1区二区| 国产激情欧美一区二区| 小说图片视频综合网站| 黄色视频,在线免费观看| 国产精品乱码一区二三区的特点| 日本成人三级电影网站| 亚洲专区中文字幕在线| 亚洲精品色激情综合| 天天躁日日操中文字幕| 国产精品亚洲av一区麻豆| 91在线观看av| 亚洲精品在线观看二区| 久久久久久国产a免费观看| 成人av在线播放网站| 午夜精品一区二区三区免费看| 女同久久另类99精品国产91| 亚洲片人在线观看| 啪啪无遮挡十八禁网站| 91麻豆av在线| 岛国在线观看网站| 天天躁狠狠躁夜夜躁狠狠躁| 久久久久久大精品| 热99在线观看视频| 国产高清有码在线观看视频| 成人鲁丝片一二三区免费| 亚洲成av人片在线播放无| 久久人人精品亚洲av| a级毛片a级免费在线| 国产视频内射| www日本在线高清视频| 色在线成人网| 亚洲精品中文字幕一二三四区| 人妻久久中文字幕网| 757午夜福利合集在线观看| 成人三级黄色视频| 久久久久久久精品吃奶| 国产精品永久免费网站| 熟女电影av网| 亚洲18禁久久av| 三级毛片av免费| 国产伦一二天堂av在线观看| 五月伊人婷婷丁香| cao死你这个sao货| 国产 一区 欧美 日韩| 老汉色∧v一级毛片| 国产亚洲欧美在线一区二区| 夜夜夜夜夜久久久久| 欧美高清成人免费视频www| 亚洲美女黄片视频| 搡老妇女老女人老熟妇| 国产激情久久老熟女| 女同久久另类99精品国产91| 国内精品美女久久久久久| 天堂动漫精品| 久99久视频精品免费| 一本综合久久免费| 美女午夜性视频免费| 午夜福利在线观看吧| 人妻丰满熟妇av一区二区三区| 精品电影一区二区在线| 天天添夜夜摸| 精品日产1卡2卡| 精品福利观看| 欧美黄色片欧美黄色片| 在线观看免费午夜福利视频| 9191精品国产免费久久| 最好的美女福利视频网| 免费大片18禁| 成人亚洲精品av一区二区| 在线a可以看的网站| av在线天堂中文字幕| 最近最新中文字幕大全电影3| 国产爱豆传媒在线观看| 制服丝袜大香蕉在线| 成熟少妇高潮喷水视频| 亚洲av五月六月丁香网| 九九久久精品国产亚洲av麻豆 | 很黄的视频免费| 特级一级黄色大片| 久久婷婷人人爽人人干人人爱| 欧美乱妇无乱码| 99久久99久久久精品蜜桃| 精华霜和精华液先用哪个| 在线观看午夜福利视频| 高潮久久久久久久久久久不卡| 大型黄色视频在线免费观看| 亚洲九九香蕉| 在线播放国产精品三级| 亚洲成人久久性| 偷拍熟女少妇极品色| 成熟少妇高潮喷水视频| 久久香蕉精品热| 久久久久久久午夜电影| 成人亚洲精品av一区二区| 夜夜看夜夜爽夜夜摸| 亚洲18禁久久av| 免费在线观看成人毛片| 久久这里只有精品19| 亚洲av中文字字幕乱码综合| 18禁黄网站禁片免费观看直播| 男人的好看免费观看在线视频| 母亲3免费完整高清在线观看| 一本精品99久久精品77| 亚洲成人中文字幕在线播放| 99国产综合亚洲精品| 久久伊人香网站| 亚洲中文字幕一区二区三区有码在线看 | 国产欧美日韩精品亚洲av| 日本黄色片子视频| 小说图片视频综合网站| 综合色av麻豆| 成人三级做爰电影| 动漫黄色视频在线观看| 我要搜黄色片| 久久人妻av系列| 欧美日本亚洲视频在线播放| 国产精品久久视频播放| 国产激情偷乱视频一区二区| 五月伊人婷婷丁香| 性色avwww在线观看| 久久久久免费精品人妻一区二区| 九九久久精品国产亚洲av麻豆 | 亚洲avbb在线观看| 999精品在线视频| 国产成人精品久久二区二区91| 日韩大尺度精品在线看网址| 免费在线观看日本一区| 老司机午夜福利在线观看视频| 黑人巨大精品欧美一区二区mp4| 国产午夜精品久久久久久| 久久草成人影院| av在线蜜桃| 亚洲av熟女| 国产成人精品久久二区二区免费| 久久婷婷人人爽人人干人人爱| 非洲黑人性xxxx精品又粗又长| 小说图片视频综合网站| 亚洲九九香蕉| 免费人成视频x8x8入口观看| 国产人伦9x9x在线观看| 神马国产精品三级电影在线观看| 麻豆av在线久日| 久久久久免费精品人妻一区二区| 宅男免费午夜| 免费看日本二区| 欧美三级亚洲精品| 狠狠狠狠99中文字幕| 成人欧美大片| 午夜免费观看网址| 久久久久国产一级毛片高清牌| 国产高清视频在线播放一区| a级毛片在线看网站| 欧美乱码精品一区二区三区| 国产精品一区二区三区四区久久| 亚洲第一欧美日韩一区二区三区| 1000部很黄的大片| 成人无遮挡网站| 亚洲欧美日韩东京热| 综合色av麻豆| 两个人看的免费小视频| 美女午夜性视频免费| 精品一区二区三区四区五区乱码| 国产99白浆流出| 久久亚洲真实| 国产精品亚洲美女久久久| 国产一区二区激情短视频| 国产又黄又爽又无遮挡在线| 午夜福利欧美成人| 两人在一起打扑克的视频| 日韩欧美 国产精品| 俺也久久电影网| 亚洲色图av天堂| 51午夜福利影视在线观看| 国产1区2区3区精品| ponron亚洲| 免费观看人在逋| 日日夜夜操网爽| 色吧在线观看| 99久久综合精品五月天人人| 好男人电影高清在线观看| 18美女黄网站色大片免费观看| 国内精品一区二区在线观看| 国产亚洲欧美在线一区二区| 久久久久久久久免费视频了| 99久久精品热视频| 少妇的丰满在线观看| 亚洲av成人不卡在线观看播放网| 久久午夜亚洲精品久久| 亚洲精品一卡2卡三卡4卡5卡| av在线天堂中文字幕| 国产1区2区3区精品| 丰满人妻一区二区三区视频av | 国产精品久久久人人做人人爽| 欧美3d第一页| 久久久久久九九精品二区国产| 久久午夜亚洲精品久久| 午夜福利在线观看免费完整高清在 | 国产乱人视频| 亚洲五月婷婷丁香| 亚洲专区国产一区二区| av视频在线观看入口| 成人永久免费在线观看视频| 老汉色av国产亚洲站长工具| av女优亚洲男人天堂 | av天堂在线播放| 亚洲欧美日韩卡通动漫| 色尼玛亚洲综合影院| 欧美日韩综合久久久久久 | 老司机在亚洲福利影院| 国产精品影院久久| 啦啦啦免费观看视频1| 久久中文看片网| 久久久精品欧美日韩精品| 免费在线观看亚洲国产| 久久精品亚洲精品国产色婷小说| av国产免费在线观看| 欧美xxxx黑人xx丫x性爽| 日日摸夜夜添夜夜添小说| 搡老岳熟女国产| 男人的好看免费观看在线视频| 男女午夜视频在线观看| 一个人观看的视频www高清免费观看 | 五月伊人婷婷丁香| 嫁个100分男人电影在线观看| 免费观看精品视频网站| 亚洲自拍偷在线| 午夜精品久久久久久毛片777| 亚洲精品在线美女| 男人的好看免费观看在线视频| 黄色成人免费大全| 男女视频在线观看网站免费| 婷婷亚洲欧美| 亚洲欧美日韩卡通动漫| 久久久久国产精品人妻aⅴ院| 黄频高清免费视频| 欧美乱色亚洲激情| 俄罗斯特黄特色一大片| 成人永久免费在线观看视频| 免费看美女性在线毛片视频| 国产精品亚洲美女久久久| 制服丝袜大香蕉在线| 国产成+人综合+亚洲专区| 久久久久久大精品| 亚洲国产欧美网| a级毛片a级免费在线| 9191精品国产免费久久| or卡值多少钱| 香蕉久久夜色| 观看美女的网站| 国产精品国产高清国产av| 免费人成视频x8x8入口观看| 欧美激情久久久久久爽电影| 日日干狠狠操夜夜爽| 天天一区二区日本电影三级| а√天堂www在线а√下载| 欧美精品啪啪一区二区三区| av视频在线观看入口| 亚洲国产精品合色在线| 亚洲aⅴ乱码一区二区在线播放| 国产乱人伦免费视频| 天天躁日日操中文字幕| 久久国产精品影院|